<?xml version="1.0" encoding="UTF-8"?>
<p id="para50">Fourth, antiviral drugs suggested to be active against SARS-CoV-2 (ie, remdesivir or lopinavir–ritonavir) can be considered as compassionate treatment, as done in adults, after careful consideration of the risk-benefit ratio and technical issues. The pharmacology of intravenous remdesivir is unknown and it might not be widely available, whereas lopinavir–ritonavir is safe during pregnancy but is only available in tablets.
 <xref rid="bib5" ref-type="bibr">5</xref>, 
 <xref rid="bib6" ref-type="bibr">6</xref> Whether SARS-CoV-2 can be vertically transmitted remains unclear, although some cases reported by the media seem to exclude it.
</p>
